Related Experiment Video
Updated: Sep 30, 2025

Gene Digital Circuits Based on CRISPR-Cas Systems and Anti-CRISPR Proteins
Published on: October 18, 2022
CRISPR signal conductor 2.0 for redirecting cellular information flow.
Yonghao Zhan1,2, Aolin Li1,3, Congcong Cao1
1Guangdong Key Laboratory of Systems Biology and Synthetic Biology for Urogenital Tumors, Shenzhen Institute of Translational Medicine, Health Science Center, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, Guangdong, China.
This study introduces CRISPR signal conductor 2.0, an advanced artificial gene circuit system that improves signal processing and gene delivery. The new system enables precise targeting of cancer cells for gene therapy by integrating long noncoding RNA motifs.
Area of Science:
- Synthetic Biology
- Gene Circuit Engineering
- CRISPR Technology
Background:
- Designing intelligent artificial gene circuits requires flexible component connections and coupling with endogenous signaling pathways.
- Existing CRISPR signal conductors face challenges in multiple signal processing and gene delivery.
Purpose of the Study:
- To develop an improved CRISPR signal conductor (version 2.0) by integrating long noncoding RNA (lncRNA) functional motifs.
- To enhance signal processing capabilities and gene delivery efficiency in artificial gene circuits.
- To enable precise targeting of cancer cells for in vivo gene therapy.
Main Methods:
- Integration of diverse lncRNA functional motifs into the crRNA of the CRISPR-dCasΦ system.
- Development of a novel system for regulating target gene expression via endogenous transcription factor recruitment.
- Construction and testing of logic gates with up to six input signals.
Main Results:
- The CRISPR signal conductor 2.0 system demonstrated enhanced sensing of various protein signals.
- Addressed issues of background leakage and insensitive signaling responses.
- Successfully constructed logic gates with high input signal capacity for specific cancer cell targeting.
Conclusions:
- CRISPR signal conductor 2.0 offers a robust platform for advanced artificial gene circuit design.
- The system shows significant potential for in vivo cancer gene therapy by rewiring endogenous signaling networks.
- Demonstrated effectiveness and biosafety for therapeutic applications.
Related Concept Videos
CRISPR/Cas9 Genome Editing
Homologous Recombination
The Antiviral System of Bacteria and Archaea: CRISPR
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

